Clinical trial
LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors…
NCT00003706 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00003706 |
|---|---|
| Title | LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function |
| Official title | A Phase I Pharmacokinetic Trial of LY231514 Administered Intravenously Every 3 Weeks in Advanced Cancer Patients With Varying Degrees of Renal Function |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | Lily Research Laboratories National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | pemetrexed disodium |
| Enrollment | 50 |
| Start date | Apr 1, 1998 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Mar 15, 2004 |
| Last update posted | Jun 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: